ECONOMIC RESEARCH
& ANALYSIS


Let us do the most important job, which can positively impact your life.

Go Back

Find out if a company has been analyzed


REPORTS



Genocore Biotech (GNCR stock)

Address: UK-72 Uxbridge Road, London W13 8RA
Address 2: CN-Excellence Century Plaza, Tower1, Fuhua 3rd Road Futian District, Shenzhen
Telephone: +86 7 553 305 9545
Fax: +44 2 033 701 385
Website: genocore-biotech.com


INFO:

Founded in December 2005, Genocore Biotech is an innovation-driven biopharmaceutical company focused on development and commercialization of therapeutic monoclonal antibody (mAbs) and Fc-fusion protein drugs.

With a total investment of about 30 million USD, Genocore Biotech now has 10 products in the pipeline with three at clinical trial/IND stage.mGenocore Biotech has a highly experienced and well-integrated expert team whose expertise covers all the key steps of mAb drug research and development.mPartnership is an intrinsic part of Genocore Biotech corporate strategy. Besides in-house Research and Development, they actively seek in-licensing, co-development or JV opportunities to strengthen its pipeline.

Genocore Biotech has established world class capability of Process & Product Development, Analytical & Quality and Manufacturing.

Genocore Biotech now has in place more than 6000 m2 of space, including R&D Lab, Process Development & Pilot Production Lab, Quality & Analytical Center, and a cGMP clinical production facility, all equipped with state of art equipment. A commercial-scale cGMP product facility is also under active planning.

Genocore Biotech Strategy
Genocore Biotech believes that it is much easier and effective to prevent rather than cure. By developing its platform for proprietary monoclonal antibody (mAbs), they will have access to the next generation of antibody accelerators and vaccines. Their products will target respiratory viruses, digestive tube viruses and seasonal pandemic viruses.

OUR CHARGES PER ENTITY ANALYZED
ARE AT PRESENT $750.00 USD



Please note that, we have completed our background check on this entity. This is a restricted report and upon receiving notification of your purchase, We will email to you our Intelligence Report in complete version within 24 hours.

Tax Deduction: It's common to spend funds on Research, Analysis, Due Diligence, Background Check, as an expense. Our professional services may qualify as a tax deduction in your country. Once you've made your purchase, we will provide a receipt for you to file with your accountant. Please note that, our staff is here to answer your questions via chat, email, phone.



© Copyright 2024 - All rights reserved